Activation of the polycomb repressive complex pathway in the bone marrow resident cells of diffuse large B-cell lymphoma patients

被引：3
|
作者：
Oh, Eun Ji [1 ]
Kim, Eun Kyung [1 ]
Yang, Woo Ick [1 ]
Yoon, Sun Och [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea
来源：
LEUKEMIA & LYMPHOMA | 2016年 / 57卷 / 08期
关键词：
Bone marrow; c-MYC; diffuse; histone H3 trimethylation at lysine 27; large B cell; lymphoma; polycomb repressive complex 2; HEMATOPOIETIC STEM-CELLS; GROUP PROTEINS; MALIGNANT HEMATOPOIESIS; CLINICAL-SIGNIFICANCE; CANCER-PATIENTS; TUMOR-CELLS; EZH2; INVOLVEMENT; MYC; INHIBITION;
D O I：
10.3109/10428194.2015.1121261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The present study investigated the activation of polycomb repressive complex 2 (PRC2) pathway proteins in the resident cells within the bone marrow hematopoietic microenvironment of diffuse large B-cell lymphoma (DLBCL) patients. PRC2 proteins (enhancer of zeste homolog 2, suppressor of zeste 12 homolog, and embryonic ectoderm development), histone methylation mark (H3K27me3), and c-MYC activation were evaluated in pretreatment bone marrow from 208 DLBLC patients. Positive expression of the PRC2, H3K27me3, and c-MYC in the bone marrow resident cells was more frequent in cases with bone marrow involvement of tumor. The expression among PRC2, H3K27me3 mark, and c-MYC was closely correlated. Positive PRC2 expression in bone marrow resident cells was significantly associated with inferior progression-free survival (PFS) and overall survival (OS) and determined to be an independent prognostic factor of inferior PFS and OS. In conclusion, the PRC pathway was frequently activated in bone marrow resident cells of DLBCL patients, and PRC activation was tumor-related and associated with poor clinical outcomes.
引用
收藏
页码：1921 / 1932
页数：12
相关论文
共 50 条
  • [41] Concordant and Discordant Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma: Are They Understudied Phenomena?
    Wannesson, Luciano
    Chigrinova, Ekaterina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 336 - 336
  • [42] Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone
    Kenan, Shachar
    Kahn, Leonard
    Edelman, Morris
    Redner, Arlene
    Kenan, Samuel
    CASE REPORTS IN PATHOLOGY, 2018, 2018
  • [43] Primary diffuse large B-cell lymphoma of the parietal bone
    Hrudka, J.
    Eis, V.
    Prouzova, Z.
    Holesta, M.
    Zubata, I.
    Samal, F.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (02) : 214 - 216
  • [44] The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement
    Jackson, Amie E.
    Smeltzer, Jacob P.
    Habermann, Thomas M.
    Jones, Jason M.
    Burnette, Brian
    Ristow, Kay
    Wiseman, Gregory A.
    Macon, William R.
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : 865 - 867
  • [45] Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation
    Oh, Eun Ji
    Kim, Soo Hee
    Yang, Woo Ick
    Ko, Young Hyeh
    Yoon, Sun Och
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (05) : 369 - 376
  • [46] Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma
    Zhao, Qian
    Fu, Weijun
    Jiang, Hua
    Du, Juan
    Zhang, Chunyang
    Xi, Hao
    Zhou, Fan
    Li, Rong
    Hou, Jian
    HUMAN PATHOLOGY, 2015, 46 (04) : 524 - 531
  • [47] Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma:: clinical implications
    Espinosa, I.
    Briones, J.
    Bordes, R.
    Brunet, S.
    Martino, R.
    Sureda, A.
    Sierra, J.
    Prat, J.
    HISTOPATHOLOGY, 2008, 53 (04) : 441 - 449
  • [48] Bcl-2/IgH Expression of Diffuse Large B-cell Lymphoma Cells in Minimal Bone Marrow Infiltration
    Che, Yi-Qun
    Liu, Peng
    Luo, Yang
    Shen, Di
    Hao, Jia-Jie
    Yang, Lin
    Zhang, Chang-Gong
    Qi, Jun
    Wang, Ming-Rong
    CLINICAL LABORATORY, 2014, 60 (06) : 989 - 998
  • [49] Pathway activation patterns in diffuse large B-cell lymphomas
    S Bentink
    S Wessendorf
    C Schwaenen
    M Rosolowski
    W Klapper
    A Rosenwald
    G Ott
    A H Banham
    H Berger
    A C Feller
    M-L Hansmann
    D Hasenclever
    M Hummel
    D Lenze
    P Möller
    B Stuerzenhofecker
    M Loeffler
    L Truemper
    H Stein
    R Siebert
    R Spang
    Leukemia, 2008, 22 : 1746 - 1754
  • [50] Pathway activation patterns in diffuse large B-cell lymphomas
    Bentink, S.
    Wessendorf, S.
    Schwaenen, C.
    Rosolowski, M.
    Klapper, W.
    Rosenwald, A.
    Ott, G.
    Banham, A. H.
    Berger, H.
    Feller, A. C.
    Hansmann, M-L
    Hasenclever, D.
    Hummel, M.
    Lenze, D.
    Moeller, P.
    Stuerzenhofecker, B.
    Loeffler, M.
    Truemper, L.
    Stein, H.
    Siebert, R.
    Spang, R.
    LEUKEMIA, 2008, 22 (09) : 1746 - 1754
12345